Related Experiment Video
Updated: Jul 14, 2025
Intramyocardial Transplantation of MSC-Loading Injectable Hydrogels after Myocardial Infarction in a Murine Model
Published on: September 20, 2020
Exosome-bearing hydrogels and cardiac tissue regeneration
Hassan Amini1,2, Atieh Rezaei Namjoo1, Maryam Taghavi Narmi3
1Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Insights
Exosomes (Exos) within hydrogels show promise for treating myocardial infarction (MI) by delivering therapeutic agents to damaged heart tissue. This approach aims to overcome limitations of traditional stem cell therapies for cardiac repair.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Nanotechnology
Background:
- Myocardial infarction (MI) is a leading cause of death, with limited cardiac repair capacity.
- Current stem cell and exosome (Exos) therapies face challenges like short lifespan and immune rejection.
- Minimally invasive therapeutic strategies are needed for effective cardiac function restoration.
Purpose of the Study:
- To review recent advances in using exosome-loaded hydrogels for ischemic cardiac tissue.
- To evaluate how tissue engineering enhances exosome and cell-based therapies under ischemia.
- To highlight the role of nanotechnology and nanobiology in developing smart biomaterials for cardiac repair.
Main Methods:
- Review of current literature on exosome-loaded hydrogels in cardiac tissue engineering.
- Analysis of nanotechnology and nanobiology applications in biomaterial design.
- Focus on therapeutic outcomes in ischemic conditions.
Main Results:
- Hydrogels serve as effective platforms for delivering exosomes and other bioactive factors directly into the myocardium.
- Tissue engineering strategies can improve the efficiency of exosome-based therapies.
- Nanotechnology enables the design of advanced biomaterials for cardiac repair.
Conclusions:
- Exo-loaded hydrogels offer a promising approach for direct myocardial injection of therapeutics.
- Further research on hydrogel physicochemical properties is crucial for clinical translation.
- This strategy holds potential for improving treatment options for patients with MI.
Background:
In recent years, cardiovascular disease in particular myocardial infarction (MI) has become the predominant cause of human disability and mortality in the clinical setting. The restricted capacity of adult cardiomyocytes to proliferate and restore the function of infarcted sites is a challenging issue after the occurrence of MI. The application of stem cells and byproducts such as exosomes (Exos) has paved the way for the alleviation of cardiac tissue injury along with conventional medications in clinics. However, the short lifespan and activation of alloreactive immune cells in response to Exos and stem cells are the main issues in patients with MI. Therefore, there is an urgent demand to develop therapeutic approaches with minimum invasion for the restoration of cardiac function.
Main Body:
Here, we focused on recent data associated with the application of Exo-loaded hydrogels in ischemic cardiac tissue. Whether and how the advances in tissue engineering modalities have increased the efficiency of whole-based and byproducts (Exos) therapies under ischemic conditions. The integration of nanotechnology and nanobiology for designing novel smart biomaterials with therapeutic outcomes was highlighted.
Conclusion:
Hydrogels can provide suitable platforms for the transfer of Exos, small molecules, drugs, and other bioactive factors for direct injection into the damaged myocardium. Future studies should focus on the improvement of physicochemical properties of Exo-bearing hydrogel to translate for the standard treatment options.
